Key result
In a 35-year-old woman with fulminant peripartum cardiomyopathy, cardiac function progressively improved and stabilized following the implantation of a left ventricular assist device.
Case Report (n=1)
Fulminant peripartum cardiomyopathy can present with massive respiratory dysfunction and may require mechanical circulatory support such as an LVAD when medical therapy fails.
May support LVAD use in refractory peripartum cardiomyopathy; leaves open need for prospective data on outcomes and selection.
OBJECTIVE: Case report of a 35-year-old gravida 3, para 2, at 40 + 6 weeks with massive respiratory dysfunction with need of oxygenation, requiring cesarean section. CASE REPORT: Postpartum investigations revealed pathological cardiomegaly with left ventricular failure (NYHAIV). Cardiac biopsy diagnosed postpartum dilatative cardiomyopathy. Despite medication with bromocriptine and levosimendan, cardiac function continued to decrease, requiring surgical intervention and implantation of an intracorporal, left ventricular assist device. Following surgery, cardiac function progressively improved and stabilized. OBJECTIVE: Peripartum cardiomyopathy (PPCM) is a rare, pregnancy-induced disease and requires an interdisciplinary approach for diagnostics and therapeutical treatment.
No takes yet. Share an insight, caveat, or question.
Freerksen et al. (2012) conducted a case report in Peripartum cardiomyopathy (PPCM) (n=1). Left ventricular assist device (LVAD) implantation was evaluated on Cardiac function improvement and stabilization. In a 35-year-old woman with fulminant peripartum cardiomyopathy, cardiac function progressively improved and stabilized following the implantation of a left ventricular assist device.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: